Used in the treatment of bronchial asthma in patients who have not achieved adequate control with previous therapy using bronchodilators and/or antiallergic medications.
The active substance is budesonide.
Each inhalation contains 200 micrograms of budesonide.
Other ingredients: oleic acid, ethanol, and 1,1,1,2-tetrafluoroethane (HFA-134a).
Budesonide is a non-halogenated corticosteroid, effective in the treatment of asthma due to its anti-inflammatory properties.
It is prescribed for:
Treatment of bronchial asthma in patients who have not responded adequately to bronchodilators and/or antiallergic therapy.
Always follow your doctor’s or pharmacist’s instructions regarding the use of Budesonide Aldo-Union 200 micrograms. If in doubt, consult them.
This medication is administered via inhalation.
Dosage must be individualized.
Children and adolescents:
Ages 2–7 years: 200–400 mcg per day, divided into 2–4 doses.
Children over 7 years: 200–800 mcg per day, divided into 2–4 doses.
Adults:
Adults: 200–1600 mcg per day, divided into 2–4 doses.
Once the desired clinical response is achieved, the maintenance dose should be gradually reduced to the lowest effective dose for symptom control.
Always check the expiration date before use.
Remove the protective cap.
If the inhaler is new or hasn’t been used for several days, shake it well and test spray once to ensure it works properly.
For regular use, follow these steps:
Your doctor should ensure you know how to use the inhaler properly and coordinate breathing with inhalation.
The inhaler has a dose counter, visible through a small hole or window on the button.
A new inhaler will display “120” or “200” depending on the canister size prescribed.
The dose counter rotates downward every 5–7 sprays.
When approximately 40 doses remain, the indicator changes color from green to red to alert the patient.
Discard the inhaler when the indicator reaches “0”.
Keep out of reach of children.
Store at temperatures below 30°C.
Protect from direct sunlight.
Do not freeze or refrigerate.